Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

Absci (ABSI) and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients. Through this strategic partnership, Absci and ...

Nurses and other health care workers in Michigan want increased wages, better benefits, and improved working conditions. The five-day strike will start Jan. 20. More industry news is about Blue Shield ...

Absci Corp (ABSI) stock saw a modest uptick, ending the day at $3.22 which represents a slight increase of $0.15 or 4.89% from the prior close of $3.07. The stock opened at $4.09 and touched a low of ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

In a strategic move to expand its footprint in the healthcare sector, Advanced Micro Devices (AMD) has announced a $20 ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...